AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ringraf 1.0mg Tablet

Prescription Icon
Prescription Required

Marketer

Rindz Pharma

Salt Composition

Tacrolimus (1.0mg)

Overview Ringraf 1.0mg Tablet

Following a transplant (e.g., liver, kidney, or heart), Immusan 1mg tablets, used in conjunction with other medications, help prevent organ rejection by suppressing the immune system's attack on the new organ. This immunosuppressant's dosage and frequency depend on your transplant type, weight, and other medications. Adhere strictly to your physician's instructions. Take it on an empty stomach, at least one hour before or two hours after eating. Consistent use maximizes benefits; discontinuation increases rejection risk. Immusan 1mg carries potential side effects, including worsened diabetes or kidney issues (requiring immediate medical attention), tremor, infections, hypertension, headache, and insomnia. Report persistent or worsening side effects. Reduced immunity increases infection susceptibility. Inform your doctor of pre-existing kidney, liver, heart problems, diabetes, or hypertension, and all other medications (especially those for infections, pain, or arthritis), as interactions are possible. Limit sun and UV exposure due to increased skin cancer risk. Effective contraception is crucial for both men and women. Pregnancy and breastfeeding use should be carefully considered and only with explicit medical necessity. Regular medical check-ups, including frequent blood pressure monitoring, are essential throughout treatment.

Uses of Ringraf 1.0mg Tablet

Avoiding transplant organ rejection

Major Benefits of Ringraf 1.0mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Ringraf 1.0mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Ringraf 1.0mg Tablet:

  • High blood pressure
  • Increased glucose level in blood
  • Kidney damage
  • Insomnia (difficulty in sleeping)
  • Tremors
  • Headache
  • Abnormal liver function tests
  • Infection

How to use Ringraf 1.0mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Ringraf 1.0mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Ringraf 1.0mg Tablet works:

Immunosuppressant Ringraf 1.0mg tablets reduce the body's immune reaction after organ transplantation (such as liver, kidney, or heart). This action promotes the body's acceptance of the transplanted organ.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Ringraf 1.0mg Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ringraf 1.0mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Ringraf 1.0mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking a 1mg Ringraf tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ringraf 1.0mg Tablets cautiously; dosage modification may be necessary. A physician's consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Ringraf 1.0mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Ringraf 1.0mg Tablet :

Should you forget a Ringraf 1.0mg Tablet dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Ringraf 1.0mg Tablet

LabelValue
Chemical Category Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Ringraf 1.0mg Tablet

Ringraf 1.0mg tablets are macrolide antibiotics primarily used post-organ transplantation. Their immunosuppressant action helps prevent rejection following kidney, heart, or liver transplants.
While using Ringraf 1.0mg Tablet, avoid live vaccines (weakened but live pathogens). This includes measles, mumps, rubella, BCG (TB), yellow fever, chickenpox, typhoid vaccines, oral polio drops, and nasal flu vaccines.
Ringraf 1.0mg Tablet should be avoided by individuals with allergies to its components, weakened immune systems, high blood pressure, or kidney failure. Pregnant or breastfeeding women, and those planning to receive live vaccines (such as MMR), should also avoid this medication.
Tell your doctor if you are pregnant, have allergies, a chronic infection, high blood sugar, or high blood pressure. Also inform your doctor about high potassium levels, a weakened immune system, any past medication use, recent vaccines, or upcoming live vaccinations.
Ringraf 1.0mg Tablet weakens the immune system, increasing the risk of infection and, in some cases, cancers such as skin and lymphoma. This medication reduces your body's ability to fight infections. Consult your doctor before use and immediately if you experience infection symptoms like fever, chills, sweats, cough, flu-like symptoms, muscle aches, or skin redness, warmth, or pain.
Ringraf 1.0mg tablets are not controlled substances because they lack abuse potential. Controlled substances require authorization from medical professionals and regulatory bodies due to their potential for misuse.
Ringraf 1.0mg Tablet
336
MRP 390
13% off